Simons et al. explored the hypothesis that the Akt inhibitor, perifosine (PER), combined with inhibitors of glutathione (GSH) and thioredoxin (Trx) metabolism induces cytotoxicity via metabolic oxidative stress in human head and neck cancer (HNSCC) cells. The gene discussed is TXN; the disease is head and neck squamous cell carcinoma.